Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Organogenesis

Organogenesis
1985 FOUNDED
PRIVATE STATUS
601-700 EMPLOYEES
PIPE LATEST DEAL TYPE
7 FINANCING ROUNDS
4 INVESTMENTS
Description

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Ownership Status
Privately Held (backing)
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Former Stock Listing
ORGO
Primary Office
  • 85 Dan Road
  • Canton, MA 02021
  • United States

+1 (781) 000-0000

Organogenesis Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Organogenesis‘s full profile, request access.

Request full access to PitchBook

Organogenesis Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
000000000 Corporation Melbourne, Australia 00 00000 000000000 00000
000000 Corporation Malvern, PA 00 00.00 000000000000 00.00
00000000 Venture Capital-Backed Durham, NC 00 00000 000000000000 00000
000000 00000000000 Formerly VC-backed Columbia, MD 000 000.00 000000&0 000.00
To view this company’s complete list of competitors, request access »

Organogenesis Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000000000 10-Dec-2018 000000000000000000 Holding Companies 0000 0000000000 00.
000000 0000000 28-Mar-2017 000000000000000000 Surgical Devices 0000 0000000000 00.
00000 (0000000000 17-Jan-2014 000000000000000000 00000 Pharmaceuticals
NanoMatrix 25-Feb-2008 Merger/Acquisition Biotechnology 00000 000000
To view this company’s complete investment and acquisition history, request access »

Organogenesis Subsidiaries (1)

Company Name Industry Location Founded
000000 0000000 Surgical Devices Birmingham, AL 0000
To view this company’s complete subsidiary history, request access »

Organogenesis Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Organogenesis‘s full profile, request access.

Request full access to PitchBook

Organogenesis Executive Team (7)

Name Title Board
Seat
Contact
Info
Gary Gillheeney Sr. Chief Executive Officer & Board Member
Timothy Cunningham Chief Financial Officer & Chief Accounting Officer
Patrick Bilbo Chief Operating Officer
Brian Grow Executive
Howard Walthall JD Executive Vice President

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

Organogenesis Board Members (6)

Name Representing Role Since Contact
Info
0000 0000 Organogenesis Board Member 000 0000
0000 0000000000 00. Organogenesis Chief Executive Officer & Board Member 000 0000
000000 00000000 Self Board Member 000 0000
0000000 0000 Organogenesis Board Member 000 0000
00000 000000 Organogenesis Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »